← All indications
Dermatofibrosarcoma
A sarcoma of the deep layers of the skin. The tumors are locally aggressive tends to recur but rarely metastatic. It can be classified into variants depending on the cell type tumors are derived from or by its characteristics: Pigmented variant from MELANIN-containing DERMAL DENDRITIC CELLS; Myxoid variant, myxoid STROMAL CELLS; Giant cell variant characterized by GIANT CELLS in the tumors; and Fibrosarcomatous variant chracterized by tumor areas histologically indistinguishable from FIBROSARCOMA.
Drugs by status
Phase 3 trials (2)
Phase 2 trials (5)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (13)
- Celgene
- Novartis
- GlaxoSmithKline
- Cornell University
- Katholieke Universiteit Leuven
- Sarcoma Alliance for Research through Collaboration
- Southwest Oncology Group
- University of Michigan
- University of Toronto
- Dermatologic Cooperative Oncology Group
- University of Mannheim
- European Organisation for Research and Treatment of Cancer
- University of Paris
Organization Involved with Phase 1 Indications (1)